In a first-of-its-kind unusual case, a doctor ‘transplanted’ cancer accidentally into his own body while performing surgery to remove a tumour from a 32-year-old patient who later died of ...
A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod.
Under the agreement, Neomorph will receive an undisclosed upfront payment from AbbVie and be eligible for up to $1.64 billion in aggregate option fees and milestones.